Noliterax (Indapamide, Perindopril Arginine)

Noliterax is used in the management of arterial hypertension, a major cardiovascular disease category.

• Essential hypertension: lowers systolic and diastolic blood pressure in patients with primary hypertension.
• Stage 1 hypertension: provides adequate blood‑pressure control when monotherapy is insufficient.
• Stage 2 hypertension: contributes to target‑organ protection when combined with lifestyle measures.

• Indapamide acts as a thiazide‑like diuretic by inhibiting sodium reabsorption in the distal tubule, increasing urinary excretion of sodium and water. Perindopril arginine is an angiotensin‑converting‑enzyme (ACE) inhibitor that blocks conversion of angiotensin I to angiotensin II, leading to vasodilation, reduced aldosterone secretion, and decreased peripheral resistance, together producing a synergistic antihypertensive effect.

Common Side Effects

• Dizziness: transient light‑headedness, especially after the first doses.
• Headache: mild to moderate intensity, often resolves with continued therapy.
• Cough: dry, non‑productive cough related to ACE inhibition.
• Fatigue: general tiredness without specific cause.
• Electrolyte imbalance: mild changes in sodium or potassium levels.
• Increased urination: due to the diuretic component.

Serious or Rare Side Effects

• Angioedema: swelling of face, lips, tongue, or airway requiring emergency care.
• Severe hypotension: marked drop in blood pressure causing fainting.
• Renal impairment: worsening kidney function, particularly in patients with pre‑existing disease.
• Hyperkalemia: elevated potassium that may cause cardiac arrhythmias.
• Pancreatitis: abdominal pain with elevated enzymes.
• Blood dyscrasias: rare blood cell abnormalities such as agranulocytosis.

Before prescribing Noliterax, clinicians should evaluate patient‑specific factors and monitor therapy closely.

• Renal function: assess baseline creatinine and eGFR, adjust if impaired.
• Electrolytes: monitor serum sodium and potassium regularly.
• Pregnancy: use only if potential benefit justifies potential risk to the fetus.
• Elderly: initiate at the lowest effective dose and titrate cautiously.
• Concomitant ACE inhibitors or ARBs: avoid duplication to reduce risk of hyperkalemia.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Noliterax may interact with several medicines; careful review is required.

Major Interactions (Avoid)

• Lithium: increased lithium levels may cause toxicity.
• Potassium‑sparing diuretics or supplements: risk of hyperkalemia.
• NSAIDs: may blunt antihypertensive effect and affect renal function.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: additive blood‑pressure lowering effect.
• Other diuretics: may enhance diuresis and electrolyte shifts.
• Antidiabetic agents: potential for enhanced hypoglycaemia, monitor glucose.